Key result
Lamotrigine may trigger proarrhythmias and false-positive sodium channel blockade tests in Brugada syndrome.
Why the study?
Guidance regarding which antiepileptic medications should be withheld during sodium channel blockade testing for Brugada syndrome is limited, particularly concerning lamotrigine.
Does lamotrigine cause proarrhythmogenic effects during ajmaline testing for Brugada syndrome?
Case Report
Does lamotrigine cause proarrhythmogenic effects during ajmaline testing for Brugada syndrome?
Lamotrigine may be proarrhythmogenic or cause false-positive results during ajmaline testing for Brugada syndrome, suggesting it should be considered for withholding prior to testing.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to possible false-positive ajmaline tests with lamotrigine in Brugada syndrome; hypothesis-generating and warrants prospective validation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Leong et al. (2017) conducted a case report in Brugada syndrome and epilepsy. Lamotrigine during ajmaline testing was evaluated. Lamotrigine is potentially proarrhythmogenic during sodium channel blockade testing in patients with Brugada syndrome, and may cause a false-positive result.
Synapse has enriched 10 related papers. Consider them for comparative context: